mounjaro

A man in Gurgaon was allegedly producing fake mounjaro injections and selling his own unapproved brand, 'Toneup', disguised as a Japanese product. Authorities recalled 22 Toneup injections after tracing sales to multiple cities. The accused learned to make injections using online resources and sourced materials from China.

Experiencing hair loss while losing weight is a common physiological reaction as the body enters 'survival mode.' Rapid weight loss, often triggered by extreme diets or weight-loss medications, can push hair follicles into a resting phase. Let's know more about this issue.

Authorities have uncovered a dual operation in Gurgaon where a man manufactured fake mounjaro injections and an unapproved tirzepatide-based product named 'Toneup'. Using 3D printing for packaging, he sold these counterfeit and unapproved vials online, with some traced to buyers in Delhi and Hyderabad. The investigation is ongoing, and an immediate recall has been initiated.

Raw Material Source Tracked, Flat In Gurgaon Used to Assemble Injections

Rapid weight loss from mounjaro can lead to a phenomenon dubbed 'mounjaro face,' characterised by hollowed cheeks, prominent lines, and skin looseness. Experts advise a slower weight loss pace, adequate protein, and consistent skincare to mitigate these visible facial changes. Nutritional support and hydration are also crucial for skin health during this process.

It is not a quick fix. It is not your ‘next-generation weight-loss drug’. It is not a cosmetic solution or something to include in a pre-wedding routine, experts warn. Despite that, the popularity of mounjaro continues to quietly reshape the narrative around fitness, beauty and confidence

In a significant crackdown in Gurgaon, law enforcement dismantled a counterfeit drug operation, arresting two suspects with illicit mounjaro KwikPen injections worth over ₹70 lakh. Investigators found serious labeling flaws and that the injections were improperly stored, deviating from the required 2°C to 8°C temperature range. The seized goods included dosages ranging from 2.

Affordable generic versions of Ozempic and Wegovy have quickly secured 20% of the Rs 1,600 crore weight-loss market following patent expiry. Early movers like Torrent and Sun Pharma are challenging Eli Lilly's mounjaro, with generics and lower pricing boosting semaglutide's market position.

New research reveals genes influence weight loss and nausea from Ozempic and mounjaro. A study of nearly 28,000 people found specific genetic variants predict drug effectiveness and side effects. This breakthrough could lead to personalized prescriptions, helping doctors tailor treatments for millions. Doctors may soon use genetic tests to set realistic expectations and choose the best drug for each patient.

An Instagram reel sparks a deep dive into weight-loss peptides, leading many in India to import unapproved, trial-stage medications from China. Driven by cost and the desire to overcome weight-loss plateaus, individuals are navigating AI-simplified science and online communities to obtain these substances, bypassing official medical channels.

Influencers and online communities are driving a surge in unapproved weight-loss peptides imported from China. This trend is fueled by the high cost of doctor-prescribed medications and the desire to overcome weight-loss plateaus, as the body can adapt to even potent GLP-1 drugs, leading to weight regain.

The UAE has approved Foundayo (orforglipron), Eli Lilly's once-daily oral obesity pill, becoming one of the first countries globally to offer a needle-free alternative. This GLP-1 receptor agonist mimics natural hormones to regulate appetite and blood sugar, aiding weight loss and improving metabolic health. Available by prescription from May 2026, it's intended for long-term use alongside lifestyle changes.

Online forums are leading Indians to experimental weight-loss drugs not yet approved for use. What follows is a murky chain of Chinese suppliers, local sellers, imports and self-injection that has doctors worried